Evidence map›Paper›PMID 39506773›Full record

Observational studyBMC pulmonary medicine2024

Update of prognosis and characteristics of chronic obstructive pulmonary disease in a real-world setting: a 5-year follow-up analysis of a multi-institutional registry.

Tomotsugu Takano, Kazuya Tsubouchi, Naoki Hamada, Katsuyuki Ichiki, Ryo Torii, Shohei Takata, Satoru Kawakami, Noriaki Nakagaki, Makoto Yoshida, Yasuhiko Kitasato and 13 more

Abstract readObservational StudyMulticenter Study
In one paragraph

Observational study in BMC pulmonary medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Five-Year Survival and Associated Factors in COPD Patients in Colombia: A Retrospective Cohort Study.International journal of chronic obstructive pulmonary disease · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Tomotsugu Takano *Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kazuya Tsubouchi *Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Naoki HamadaDepartment of Respiratory Medicine, Fukuoka University School of Medicine, Fukuoka, Japan.
Katsuyuki IchikiKirigaoka Tsuda Hospital, Kitakyushu, Japan.
Ryo ToriiDepartment of Respiratory Medicine, Wakamatsu Hospital of the University of Occupational and Environmental Health Japan, Kitakyushu, Japan.
Shohei TakataDepartment of Respiratory Diseases, NHO Fukuokahigashi Medical Center JP, Fukuoka, Japan.
Satoru KawakamiDivision of Respiratory Medicine, Kyushu Rosai Hospital, Kitakyushu, Japan.
Noriaki NakagakiDepartment of Respiratory Medicine, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan.
Makoto YoshidaDepartment of Respiratory Diseases, NHO Fukuoka National Hospital JP, Fukuoka, Japan.
Yasuhiko KitasatoDepartment of Respiratory Medicine, Japan Community Health Care Organization Kurume General Hospital, Kurume, Japan.
Kazunori TobinoDivision of Respiratory Medicine, Aso Iizuka Hospital, Iizuka, Japan.
Eiji HaradaDepartment of Respiratory Medicine, Kitakyushu Municipal Medical Center, Kitakyushu, Japan.
Hiroshi IshiiDepartment of Respiratory Medicine, Fukuoka University Chikushi Hospital, Chikushino, Japan.
Hiroshi WatayaDepartment of Respiratory Medicine, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.
Takashige MaeyamaDepartment of Respiratory Medicine, Hamanomachi Hospital, Fukuoka, Japan.
Masaki FujitaDepartment of Respiratory Medicine, Fukuoka University School of Medicine, Fukuoka, Japan.
Kazuhiro YateraDepartment of Respiratory Medicine, University of Occupational and Environmental Health Japan, Kitakyushu, Japan.
Masaki OkamotoDivision of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Hidetake YabuuchiDepartment of Health Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Fumiaki KiyomiClinical Research Support Center Kyushu, Fukuoka, Japan.
Shoji TokunagaMedical Information Center, Kyushu University Hospital, Fukuoka, Japan.
Yoichi NakanishiKitakyushu City Hospital Organization, Kitakyushu, Japan.
Isamu OkamotoDepartment of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. okamoto.isamu.290@m.kyushu-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe conducted a prospective observational study to elucidate the long-term prognosis and management of chronic obstructive pulmonary disease (COPD) in clinical practice in Japan in the mid-2010s.

methodsThis prospective cohort study included 29 facilities. Data from 427 patients clinically diagnosed with COPD, enrolled between September 2013 and April 2016, were analyzed. Interstitial pneumonia was excluded through a central multidisciplinary discussion. Follow-up data were collected for up to 5 years after patient registration.

resultsAt the time of registration, 53 patients clinically diagnosed with COPD did not have airflow limitation (AFL). In the cohort with AFL (n = 374), 232 patients completed a 5-year follow-up, while 49 patients died during the 1576.6 person-years of observation. The mean age was 71.7 years with an overall 5-year survival rate of 85.4%. Stratified by % forced expiratory volume in one second (FEV1), survival rates were 93.6% in the mild and moderate AFL group, 82.5% in the severe AFL group, and 66.1% in the very severe AFL group. The prognosis of the subpopulation without AFL was poor with a 5-year survival of 81.6%. This subpopulation exhibited respiratory symptoms, low vital capacity and total lung capacity, and emphysematous changes.

conclusionsOur study presents the 5-year survival and real-world clinical practice scenario of a prospective cohort of patients clinically diagnosed with COPD in Japan in the mid-2010s. The survival rates of our cohort were numerically better than the Japanese cohort in the 1990s, regardless of the high median age of this cohort. Overall, 12.4% of the patients in this cohort with no AFL at registration exhibited respiratory symptoms and distinct spirometric patterns, and had a poor prognosis.

Indexed as

Pulmonary Disease, Chronic ObstructiveRegistriesAgedAged, 80 and overFemaleFollow-Up StudiesForced Expiratory VolumeHumansJapanMaleMiddle AgedPrognosisProspective StudiesSeverity of Illness IndexSurvival RateVital Capacity5-year survival rateCOPDNormal spirometryReal-world registry

Identifiers

PMID39506773
PMCPMC11539611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.